CN103157085A - Drug for treating fracture - Google Patents
Drug for treating fracture Download PDFInfo
- Publication number
- CN103157085A CN103157085A CN 201310111162 CN201310111162A CN103157085A CN 103157085 A CN103157085 A CN 103157085A CN 201310111162 CN201310111162 CN 201310111162 CN 201310111162 A CN201310111162 A CN 201310111162A CN 103157085 A CN103157085 A CN 103157085A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- fructus
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating fracture. The drug is prepared from the following materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of coptis chinensis, 5-15 parts of chrysanthemum, 10-30 parts of woundwort, 1-15 parts of henbane, 10-20 parts of ephedra, 15-30 parts of pyrrosia lingua, 20-30 parts of radix semiaquilegiae, 1-20 parts of cortex acanthopanacis, 1-20 parts of celandine, 10-25 parts of lalang grass rhizome, 10-30 parts of burdock, 1-20 parts of emblic leafflower fruit, 15-20 parts of pawpaw, 10-20 parts of flowers carthami, 15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of pericarpium arecae, 15-25 parts of potentilla discolor, 10-20 parts of Chinese lantern-plant, 15-25 parts of cortex mori radicis, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of chinese azalea flower. All the components of the drug for treating fracture in the invention are natural materials, so the drug is good in safety, clear in curative effect and suitable for large-scale promotion clinically.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of fracture.
Background technology
Fracture refers to a kind of disease of causing sclerotin partially or completely to rupture due to reasons such as wound or pathology.Its main clinical manifestation is: fractures has limitation pain and tenderness, local swelling and ecchymosis occurs, and limb function position or completely lose, the completeness sclerotin still cacomelia and abnormal movement can occur.Searching for the medicine of new treatment fracture never stops.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of fracture.
in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of fracture, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Radix Semiaquilegiae 20-30 part, Cortex Acanthopancis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Arctii 10-30 part, Fructus Phyllanthi 1-20 part, Fructus Chaenomelis 15-20 part, Flos Carthami 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Pericarpium Arecae 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
preferably, the medicament for the treatment of fracture of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Radix Semiaquilegiaes, 18 parts of Cortex Acanthopanciss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Arctiis, 16 parts of Fructus Phyllanthis, 16 parts of Fructus Chaenomeliss, 17 parts, Flos Carthami, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Pericarpium Arecae, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of fracture of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, is suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, Rhizoma Coptidis 21 grams, Flos Chrysanthemi 13 grams, Herba Solidaginis 28 grams, Semen Hyoscyami 11 grams, Herba Ephedrae 17 grams, Folium Pyrrosiae 24 grams, Radix Semiaquilegiae 27 grams, Cortex Acanthopancis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Arctii 21 grams, Fructus Phyllanthi 16 grams, Fructus Chaenomelis 16 grams, Flos Carthami 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Pericarpium Arecae 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Semen Euryales 16 grams and Flos Rhododendri Mollis 24 grams, add 2000 milliliters of entry, in being housed, heated 4 hours under 80 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.
Experimental example
Physical data
Treatment patient 200 examples, wherein, male 161 examples, female's 49 examples; Age 21-84 year, average 52 years old; Consultation time 3h-19d after wound, average 3.2d; Fracture site: radius 12 examples, humerus 35 examples, chi radius 56 examples, lumbar vertebra 31 examples, neck of femur 38 examples, femoral shaft 12 examples, tibiofibula 16 examples.
Diagnostic criteria
(1) Standards of Chinese Medical Syndrome Differentiation (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease Standardization of diagnosis and curative effect [S]. Nanjing: publishing house of Nanjing University; 1994:94): pain appears in all traumatic injury; swelling, bony crepitus, abnormal movement; limb activity is limited; the dermal ecchymosis, dimly red tongue or the trace speckle is arranged, tongue is white; wiry and frequent pulse belongs to the syndrome of qi stagnation and blood stasis person.(2) the Western medicine diagnose standard (execute and offer sacriffices to the gods or the spirits of the dead, Wang Heming. bone injury science [M]. the first volume. Beijing; 2001:347-349) 1. there is direct or indirect trauma history the People's Health Publisher; 2. uncomplicated simple fracture, General Symptoms is not obvious or not serious; 3. local pain and tenderness, local swelling, dysfunction, deformity, abnormal movement, bony crepitus; .x the diagnosis that can clearly fracture of ray examination can be confirmed the localized variation such as classification of fracture, displacement mode, fracture end form, and gets rid of pathologisch Bruch.
Therapeutic Method
Use the decoction for preparing in embodiment to treat, every day 3 times, each oral 80 milliliters.Treating 3 days is 1 course for the treatment of.Allow as far as possible activity among a small circle of patient during treatment.
Criterion of therapeutical effect
Draft with reference to " traditional Chinese medical science disease Standardization of diagnosis and curative effect " (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease Standardization of diagnosis and curative effect [S]. Nanjing: publishing house of Nanjing University, 1994:94).Produce effects: union of fracture, joint motion are freely; Effectively: the most of healing of fracture, function of joint is improved; Invalid: fracture does not connect, without growth of spur, and ankylosis, function is poor.
After treating 1 course for the treatment of, find that whole 200 patients all meet the standard of produce effects, and do not find obvious untoward reaction.
Claims (3)
1. medicament for the treatment of fracture, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Radix Semiaquilegiae 20-30 part, Cortex Acanthopancis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Arctii 10-30 part, Fructus Phyllanthi 1-20 part, Fructus Chaenomelis 15-20 part, Flos Carthami 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Pericarpium Arecae 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of according to claim 1 fracture, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Radix Semiaquilegiaes, 18 parts of Cortex Acanthopanciss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Arctiis, 16 parts of Fructus Phyllanthis, 16 parts of Fructus Chaenomeliss, 17 parts, Flos Carthami, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Pericarpium Arecae, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
3. the medicament for the treatment of fracture according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310111162 CN103157085A (en) | 2013-03-22 | 2013-03-22 | Drug for treating fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310111162 CN103157085A (en) | 2013-03-22 | 2013-03-22 | Drug for treating fracture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103157085A true CN103157085A (en) | 2013-06-19 |
Family
ID=48580950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201310111162 Pending CN103157085A (en) | 2013-03-22 | 2013-03-22 | Drug for treating fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103157085A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103301364A (en) * | 2013-07-05 | 2013-09-18 | 李华 | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome |
-
2013
- 2013-03-22 CN CN 201310111162 patent/CN103157085A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103301364A (en) * | 2013-07-05 | 2013-09-18 | 李华 | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome |
| CN103301364B (en) * | 2013-07-05 | 2014-06-18 | 于志强 | Pharmaceutical composition for treating post-stroke shoulder-hand syndrome |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103157087A (en) | Drug for treating femoral head necrosis | |
| CN103223153B (en) | Medicament for treating femoral head necrosis | |
| CN103142982A (en) | Medicine for treating acute upper respiratory infection | |
| CN103157085A (en) | Drug for treating fracture | |
| CN103142987A (en) | Medicament for treating mumps | |
| CN102362928A (en) | Bone-protecting medicinal liquor and preparation method thereof | |
| CN112168929A (en) | Pharmaceutical composition and preparation method and application thereof | |
| CN103157084A (en) | Drug for treating osteoporosis | |
| CN103110923A (en) | Medical method for treating scar | |
| CN103585457A (en) | Medicament for treating bone fracture | |
| CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
| CN104043028A (en) | Externally used traditional Chinese medicine (TCM) preparation for treating fractures | |
| CN101850015B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101120981A (en) | Traditional Chinese medicine preparation for treating fracture and wound and pain and preparation process thereof | |
| CN103142977A (en) | Medicament for treating dysmenorrhea | |
| CN104043013A (en) | Externally used traditional Chinese medicine (TCM) preparation for treating fractures | |
| CN104740071B (en) | A kind of pharmaceutical composition for the treatment of fracture | |
| CN104815055A (en) | Traditional Chinese medicine for treating impotence | |
| CN103157083A (en) | Medicament for treating premature beat | |
| CN105168834A (en) | Medicine for treating scrofula and preparation method thereof | |
| CN103142984B (en) | Medicine for treating rheumatism | |
| CN103157081A (en) | Medicament for relaxing tendons and activating collaterals | |
| CN103550519A (en) | Preparation method of medicament for treating dysmenorrhea | |
| CN102133342B (en) | Bone-setting medicament | |
| CN107569556A (en) | A kind of mastitis care drug composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130619 |